IMPROVELow-Dose Ketamine for Pain Relief in Burn Wound Care
This study aims to evaluate the effectiveness of low-dose ketamine in providing pain relief for adults undergoing burn wound care.
Ketamine
+ 0.9% NaCl
Agnosia+9
+ Mental Disorders
+ Burns
Treatment Study
Summary
Study start date: July 8, 2024
Actual date on which the first participant was enrolled.This study is looking at how a low dose of ketamine, given through an infusion, might help people with burn injuries feel less pain during wound care procedures. The usual pain relief medications, like fentanyl and midazolam, don't always work well enough on their own. This research aims to see if ketamine can make a difference by improving pain relief and potentially reducing the need for opioids, which can have serious side effects. This study is important as it seeks to find better ways to manage pain for burn patients, which can improve their overall recovery experience. Participants in the study will receive either a low dose of ketamine or a placebo while undergoing their regular burn wound care. The ketamine or placebo is administered through an infusion, which means it is delivered directly into the bloodstream. The study will measure how well the ketamine reduces pain during these procedures and whether it leads to a decrease in the use of opioids. By evaluating the pain levels and opioid consumption, researchers aim to determine if ketamine can be a safer and more effective option for managing pain in burn patients.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.140 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location